{"schema_version":"secwatch.filing_event.v1","accession":"0001356576-26-000002","form_type":"8-K","ticker":"SUPN","cik":"0001356576","company_name":"SUPERNUS PHARMACEUTICALS, INC.","filed_at":"2026-02-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.908646+00:00","generated_at":"2026-05-16T02:57:21.645780+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Supernus schedules Q4 2025 earnings release for Feb 24, 2026 after market close","bullets":["Q4 and full year 2025 results to be reported after market close on February 24, 2026.","Conference call and webcast at 4:30 p.m. ET on February 24, 2026, hosted by CEO Jack Khattar and CFO Tim Dec.","No preliminary financial results or guidance provided in the announcement."],"urls":{"canonical":"https://secwatch.observer/filing/0001356576-26-000002","json":"https://secwatch.observer/filing/0001356576-26-000002.json","markdown":"https://secwatch.observer/filing/0001356576-26-000002.md","text":"https://secwatch.observer/filing/0001356576-26-000002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356576/000135657626000002/0001356576-26-000002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356576/000135657626000002/supn-20260212.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:57:21.645780+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}